据新华社1月31日电 聚焦医疗、药品、医疗器械、食品、儿童近视防护等重点民生领域加大监管力度， 市场监管总局31日发布十起违法广告典型案例，涉及儿童护眼"神器"、抗癌"神药"、长寿"圣品"、仿冒 名医名院等。 以"国宝级密药""10个诺贝尔奖得主证实""抗衰老圣品""返老还童"等虚假信息为噱头，宣称"干细胞生命 酶可以治疗癌症、心脏病""高血压一吃见效""防治老人痴呆症"等疾病预防、治疗功效，重庆林晖泰商 务信息咨询有限公司发布"986胚芽生命酶""航天长寿菌""北极星1号生物素片""军特001雨生红球藻 片"等普通食品广告，并在广告中违法使用"世界最强"等绝对化用语以及国家机关、国家机关工作人员 名义或者形象。市场监管部门对当事人罚款16万元。 杭州青碧品牌管理有限公司在"近视散光叶黄素护眼贴"广告中宣称"散光+近视，一贴恢复视力"；在"九 芝堂（维权）酸枣仁""江中制药益生菌""北京同仁堂牌人参蛹虫草高钙蛋白粉"等普通食品广告中宣称 具备"改善睡眠""促进脂肪代谢""增强免疫力""缓解疲劳"等保健功效，市场监管部门对当事人罚款19万 元。 松原肛肠医院在微信公众号、医院简介中宣称，该院为"北京'安氏疗法' ...

Core Viewpoint - The article highlights the increasing regulatory scrutiny on misleading advertisements in key consumer sectors such as healthcare, pharmaceuticals, medical devices, and food, particularly focusing on children's eye care and cancer treatment products. Group 1: Misleading Advertisements - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for advertising products like "children's lutein" and "eye protection lamp" with false claims about disease prevention and treatment [1] - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for misleading claims in its "camel milk powder" advertisements regarding health benefits [1] - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising its ceramic tableware as "Jingdezhen porcelain" [1] Group 2: Health Claims in Food Products - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising "organic perilla seed oil" with claims of cancer prevention and treatment [2] - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting products like "986 germ life enzyme" with false health claims and misleading language [2] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising "nearsightedness and astigmatism eye patches" with exaggerated claims about restoring vision [2] Group 3: Real Estate and Medical Device Misleading Claims - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising regarding unplanned facilities in its real estate promotions [3] - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health claims related to digestive issues [3] - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations for prescription drugs [3] Group 4: Regulatory Actions - In 2025, national market regulatory authorities handled 44,521 cases of advertising violations, imposing fines totaling 252 million yuan, reinforcing consumer rights protection [4]